CCC1CN(C(=O)N2CCC(C(=O)NCc3ccc(OC)cc3OC)CC2)c2cc(C)ccc2O1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?